I

    ICON PLC (ICLR)

    Official site

    HEALTHCARE • DIAGNOSTICS & RESEARCH • NASDAQ

    $164.99
    -5.03 (-2.96%)

    Market Cap: $13.12B

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    95%(38/40)
    Avg Surprise
    +0.97%
    Streak
    2 Q

    Upcoming Estimates

    Sep 30, 2026
    EPS Consensus$2.68
    Range$2.61 - $2.74
    14 analysts
    EPS Revisions
    3
    0
    7d
    3
    10
    30d
    EPS Estimate Drift
    90d ago$2.88+7.5%
    60d ago$2.70+1.0%
    30d ago$2.68+0.2%
    7d ago$2.67-0.1%
    Current$2.68
    Revenue Consensus
    $2.0B
    Range$2.0B - $2.0B
    12 analysts
    Dec 31, 2026
    EPS Consensus$2.97
    Range$2.73 - $3.24
    17 analysts
    Revenue Consensus
    $2.1B
    Range$2.0B - $2.3B
    15 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$2.97---
    Sep 26EST
    		-$2.68---
    Jun 26
    		$2.35$2.26+3.98%Beat-27.9%
    Mar 26
    		$2.22$2.16+2.78%Beat-30.4%
    Dec 25
    		$2.52$3.31-23.87%Miss-26.5%
    Sep 25
    		$3.31$3.28+0.91%Beat-1.2%
    Jun 25
    		$3.26$3.18+2.52%Beat-13.1%
    Mar 25
    		$3.19$3.09+3.24%Beat-8.1%
    Dec 24
    		$3.43$3.43+0.14%Beat-0.9%
    Sep 24
    		$3.35$3.84-12.76%Miss+1.5%
    Jun 24
    		$3.75$3.67+2.18%Beat+20.6%
    Mar 24
    		$3.47$3.41+1.76%Beat+19.7%
    Dec 23
    		$3.46$3.44+0.58%Beat+10.5%
    Sep 23
    		$3.30$3.28+0.61%Beat+10.0%
    Jun 23
    		$3.11$3.08+0.97%Beat+8.7%
    Mar 23
    		$2.90$2.87+1.05%Beat+5.1%
    Dec 22
    		$3.13$3.05+2.62%Beat+19.0%
    Sep 22
    		$3.00$2.94+2.04%Beat+17.6%
    Jun 22
    		$2.86$2.79+2.51%Beat+34.9%
    Mar 22
    		$2.76$2.69+2.60%Beat+34.0%
    Dec 21
    		$2.63$2.62+0.38%Beat+38.4%
    Sep 21
    		$2.55$2.46+3.66%Beat+48.3%
    Jun 21
    		$2.12$2.11+0.47%Beat+76.7%
    Mar 21
    		$2.06$1.97+4.57%Beat+21.2%
    Dec 20
    		$1.90$1.83+3.83%Beat+3.8%
    Sep 20
    		$1.72$1.54+11.69%Beat-1.1%
    Jun 20
    		$1.20$1.10+9.09%Beat-29.0%
    Mar 20
    		$1.70$1.70+0.00%Beat+4.3%
    Dec 19
    		$1.83$1.83+0.00%Beat+13.0%
    Sep 19
    		$1.74$1.74+0.00%Beat+13.0%
    Jun 19
    		$1.69$1.68+0.60%Beat+11.9%
    Mar 19
    		$1.63$1.60+1.88%Beat+14.8%
    Dec 18
    		$1.62$1.60+1.25%Beat+13.3%
    Sep 18
    		$1.54$1.54+0.00%Beat+14.1%
    Jun 18
    		$1.51$1.48+2.03%Beat+15.3%
    Mar 18
    		$1.42$1.42+0.00%Beat+10.1%
    Dec 17
    		$1.43$1.42+0.70%Beat+13.5%
    Sep 17
    		$1.35$1.32+2.27%Beat+13.4%
    Jun 17
    		$1.31$1.30+0.77%Beat-
    Mar 17
    		$1.29$1.28+0.78%Beat-
    Dec 16
    		$1.26$1.26+0.00%Beat-
    Sep 16
    		$1.19$1.18+0.85%Beat-

    Key Metrics

    Valuation
    P/E Ratio15.86EV/EBITDA23.52x
    Price/FCF14.21xFCF Yield7.04%
    Profitability
    Profit Margin0.33%Operating Margin9.41%
    ROE0.29%ROIC3.47%
    Financial Health
    Debt/Equity0.36xInterest Coverage3.64x
    Current Ratio0.95xQuick Ratio0.95x
    Trading Statistics
    Beta1.20Avg Volume562.87K
    52-Week High$203.9152-Week Low$66.57

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$170.21
    SMA 20$167.35
    SMA 50$167.06
    SMA 200$147.39
    EMA 10$168.87
    EMA 20$168.29
    EMA 50$162.73
    EMA 200$151.60

    MACD

    Line: 1.21Signal: 1.67Hist: -0.46

    ADX

    ADX: 17.7+DI: 23.6-DI: 20.3

    Aroon & PSAR

    Aroon Up4.0
    Aroon Down24.0
    PSAR$162.33

    Bollinger Bands

    Upper Band$176.02
    Lower Band$158.68
    %B Position1036%(Upper)
    Band Width0.36

    RSI (14-Day)

    Neutral
    46.6

    Momentum Oscillators

    Stoch %K39.3
    Stoch %D43.2
    Williams %R-76.3
    ROC (10d)-2.6%
    Momentum-4.46
    CCI (20d)-12.7
    MFI (14d)50.1

    Volatility Measures

    ATR (14d)$6.90(4.2%)
    StdDev (20d)4.34
    Hist Vol32.4%(Moderate)

    Volume Flow

    VWAP$166.32
    OBV4.8M
    AD Line37.8M
    CMF (20d)0.199

    Volume Metrics

    Avg Vol (20d)530.4K
    Vol Ratio1.3x
    VWMA (20d)$166.71

    Pivot Points

    R3$176.45
    R2$173.43
    R1$171.73
    Pivot Point$168.71
    S1$167.01
    S2$163.99
    S3$162.29

    Advanced Oscillators

    TSI5.60
    Ultimate Osc45.5
    KST10.71

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$2.06B$2.03B$2.19B$2.04B$2.02B$2.00B$2.04B$2.03B$2.12B$2.09B$2.07B$2.06B
    Cost of Revenue$1.67B$1.56B$1.69B$1.59B$1.46B$1.44B$1.44B$1.44B$1.49B$1.47B$1.45B$1.45B
    Gross Profit$388.53M$477.93M$500.89M$455.95M$561.60M$558.65M$599.37M$591.41M$626.56M$619.02M$620.52M$605.96M
    Operating Expenses$194.32M$304.19M$1.96B$197.05M$352.39M$339.09M$302.34M$305.98M$396.70M$333.52M$354.95M$341.65M
    R&D$0$0$0$0$0$0$0$0$0$0$0$0
    SG&A$194.32M$200.60M$179.70M$197.05M$205.01M$198.38M$151.44M$205.09M$194.46M$177.35M$195.56M$185.19M
    Operating Income$194.21M$173.73M$230.37M$258.90M$209.21M$219.56M$297.02M$285.43M$229.86M$285.50M$265.57M$264.31M
    Interest Income$3.15M$1.82M$1.49M$1.76M$2.05M$1.80M$3.01M$2.43M$1.24M$1.93M$1.72M$1.27M
    Interest Expense$48.79M$48.00M$40.11M$50.24M$50.15M$47.61M$51.43M$53.30M$60.84M$71.67M$81.03M$83.91M
    Income Before Tax$92.20M$127.56M$-120,502,000$38.10M$161.11M$173.75M$248.60M$234.56M$170.25M$215.76M$186.25M$181.68M
    Income Tax Expense$19.61M$22.81M$0$35.75M$-21,861,000$19.60M$-11,395,000$37.44M$23.34M$28.32M$-30,164,000$18.01M
    Net Income$72.58M$104.75M$-110,139,000$2.35M$182.97M$154.15M$260.00M$197.13M$146.91M$187.44M$216.42M$163.66M
    EBITDA$293.88M$277.33MN/A$186.84M$308.98M$317.32M$365.65M$380.90M$380.73M$436.61M$424.59M$421.99M
    EBIT$194.21M$187.00MN/A$88.34M$211.26M$221.36M$268.99M$287.87M$231.09M$287.43M$267.29M$265.58M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about ICLR

    News

    ICON plc (ICLR) Stock Analysis: Navigating Growth in Diagnostics & Research with a 7.74% Upside

    ICON plc (ICLR), a global healthcare services provider, is analyzed for its investment potential, showing a $13.29 billion market cap and a 7.74% potential upside based on analyst ratings. The company's financial stability is highlighted by its $622.6 million free cash flow, despite no dividend payouts, indicating a focus on reinvestment and growth. With diverse service offerings and a positive technical outlook, ICON is positioned for growth in the evolving healthcare industry.

    DirectorsTalk Interviews•8/25/26•
    Bullish

    ICON plc (ICLR) posts top-1% ESG score and 73% emissions cut

    ICON plc announced its 2025 ICON Cares ESG Report, achieving an EcoVadis Platinum score (top 1% of assessed organizations) and improving its CDP Climate Change score. The company significantly reduced its Scope 1 and 2 greenhouse gas emissions by 73.56% and sourced 97.05% of its global electricity from renewable sources. ICON also supported over 1,370 clinical studies for more than 411,400 patients and was recognized for its workplace culture and AI innovations.

    Stock Titan•8/20/26•
    Bullish

    ETFs Investing in ICON Plc Stocks

    This article lists various ETFs that hold ICON Plc stocks, providing a table with details such as market value, weight, issuer, management style, focus, expense ratio, AUM, price, change, relative volume, and 3-year NAV total return for each fund. The purpose is to offer investors an accessible way to explore ETFs that include ICON Plc in their holdings, highlighting the diversified opportunities and lower risk associated with such investments.

    TradingView•8/19/26•
    Somewhat-Bullish

    Icon PLC | 6-K: Report of foreign private issuer (related to financial reporting)

    This article consists solely of the title "Icon PLC | 6-K: Report of foreign private issuer (related to financial reporting)" and a single word "Document". It indicates that Icon PLC has filed a 6-K report, which is a filing submitted by foreign private issuers to the SEC to provide information not otherwise covered by forms 20-F or 40-F. The content suggests the article itself is a placeholder or an extremely brief notification of such a document.

    Moomoo•8/19/26•
    Neutral

    ICON plc (NASDAQ: ICLR) swaps secured loans for $2.15B in new notes

    ICON plc, through its subsidiary ICON Investments Six Designated Activity Company, has issued $2.15 billion in senior unsecured notes across three tranches, due in 2029, 2031, and 2036. The proceeds were used to repay outstanding secured term loans, redeem existing secured notes, and settle a bridge facility, leading to the release of collateral and subsidiary guarantees. This strategic move by ICON plc refinances existing secured debt, optimizing its capital structure.

    Stock Titan•8/18/26•
    Neutral

    Frequently Asked Questions About ICLR

    Does ICLR pay dividends?
    ICON PLC (ICLR) does not currently pay a regular dividend.
    What is ICLR's P/E ratio?
    ICON PLC has a price-to-earnings (P/E) ratio of 15.86.
    What is ICLR's market cap?
    ICON PLC (ICLR) has a market capitalization of $13.12B with a current stock price of $164.99.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In